Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3881 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Wal-Mart to sell cheap generic drugs

The world’s largest retailer said the program will be available to customers and associates of the 65 Wal-Mart, Neighborhood Market and Sam’s Club pharmacies in the Tampa Bay

Merck KGaA to gain control of Serono

The takeover comes only a few months after Serono had declared that it was no longer for sale. Merck said the acquisition will give it a market-leading multiple

Axcan terminates indigestion drug trial

The study did not demonstrate a statistically significant effect of Itopride in improving the symptoms of upper abdominal pain and fullness, and did not meet the analysis plans

Hospira acquires Mayne Pharma in $2 billion deal

The agreement is set to build on Hospira's strong position in the American generic injectables market and establish the company internationally. Hospira's acquisition of Mayne Pharma could have

Debiopharm drug gets EU orphan drug status

European orphan drug designation is granted for products intended to treat life-threatening or chronically debilitating conditions affecting no more than 5 in 10,000 persons. The EC Commission concluded